Evidence map›Paper›PMID 32304193›Full record

ArticleTurkish journal of medical sciences2020

Investigation the potential use of silver nanoparticles synthesized by propolis extract as N-acyl-homoserine lactone-mediated quorum sensing systems inhibitor

Sedef Ilk, Gamze Tan, Ezgi Emül, Necdet Sağlam

Open access · bronzeAbstract read
In one paragraph

Article in Turkish journal of medical sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Anti-QS Strategies AgainstMicroorganisms · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Sedef IlkDepartment of Immunology, Faculty of Medicine, Niğde Ömer Halisdemir University, Niğde, TurkeyORCID 0000-0002-6754-792X
Gamze TanDepartment of Biology, Faculty of Science and Letters, Aksaray University, Aksaray, TurkeyORCID 0000-0002-2755-1756
Ezgi EmülDepartment of Nanotechnology and Nanomedicine, Institute of Graduate School of Science and Engineering,Hacettepe University, Ankara, TurkeyORCID 0000-0003-3834-2260
Necdet SağlamDepartment of Nanotechnology and Nanomedicine, Institute of Graduate School of Science and Engineering,Hacettepe University, Ankara, TurkeyORCID 0000-0002-5463-8355
Hacettepe University · TRAksaray University · TRNiğde Ömer Halisdemir Üniversitesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background/aim: Quorum sensing (QS) is a chemical communication process that bacteria use to regulate virulence. Inhibition of QS (antiQS) overcomes the pathogenicity of bacteria. Silver nanoparticles (AgNPs) have been used as antimicrobials against pathogens, but have not been used against QS-mediated bacterial infection. Also, studies have been carried out on the inhibitory effects of propolis based structures on pathogen growth, but no studies have been found on their potential use as QS inhibitor. The present study aims to investigate the synthesis and characterization of silver nanoparticles (AgNPs) reduced with propolis extract (P–AgNPs) and evaluation of their antimicrobial and, for the first time, antiQS activity. Materials and methods: P–AgNPs were synthesized using with different volumes (1, 2.5 and 5 mL) of propolis extract (PE) by biological method via reduction of silver nitrate. Synthesized P–AgNPs were characterized in terms of hydrodynamic, chemical, morphological, physical, and antioxidant properties. Disc diffusion and flask incubation assays were used to evaluate the antimicrobial effect against Gram–negative bacteria (Escherichia coli, Proteus mirabilis,Proteus vulgaris,Salmonella typhimurium, Enterobacter aerogenes, Pseudomonas aeruginosa) and Gram–positive bacteria (Staphylococcus aureus, Streptococcus mutans, Bacillus thuringiensis) and QS–regulated biofilm activity against biosensor strain Chromobacterium violaceum CV026. Results: AgNPs were successfully synthesized by biological method via PE. The violacein pigment production based on the QS system was greatly inhibited by the P–AgNPs (inhibition zones: 16.22-21.48 mm and violacein inhibition: 63.16 ± 2.4-75.24 ± 3.5 %) without interfering with the growth of bacteria, which is the first report on the antiQS effect of P–AgNPs. Conclusion: Our results suggest that P–AgNPs may be potentially used to inhibit bacterial physiological processes due to the signal molecules regulates important collective behavior of bacteria. The development of such nontoxic biomaterials may have great potential to evaluate for the new medicinal substance that inhibits the pathogenic biofilms.

Indexed as

Metal NanoparticlesAnti-Bacterial AgentsBacteriaBiofilmsPropolisQuorum SensingSilverVirulenceAnti-Bacterial AgentsPropolisSilverantimicrobial agentpropolisquorum sensingsilver nanoparticlesvirulence factor

Identifiers

PMID32304193
PMCPMC7379411
OpenAlexW3016938217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.